Indo US Bio-Tech Quarterly Results

Pros & Cons

POSITIVES

Strong revenue growth in the latest quarter, indicating increasing market demand.
Improved profit margins compared to previous quarters, reflecting better cost management.
Expansion into new markets is showing early signs of success, diversifying revenue streams.

NEGATIVES

Declining net income compared to last quarter, raising concerns about profitability sustainability.
Rising raw material costs impacting overall margins, indicating potential future pressure on earnings.
Increased competition in the manufacturing sector may affect market share and pricing power.

Field	Sep 23	Dec 23	Mar 24	Jun 24	Sep 24	Dec 24	Mar 25	Jun 25
Revenue	15.81	22.11	15.77	24.72	22.17	23.56	33.39	30.77
Expenses	10.70	17.87	14.80	21.03	17.05	18.02	28.80	25.30
Operating Profit	5.12	4.24	0.97	3.69	5.12	5.54	4.58	5.47
Other Income	0	0.08	0.21	0.03	0.01	0.02	0.12	0
Interest	0.21	0.37	0.35	0.33	0.52	0.38	0.26	0.45
Depreciation	2.94	0.19	0.20	0.20	0.17	0.16	0.56	0.20
Profit Before Tax	1.97	3.75	0.63	3.19	4.45	5.02	3.88	4.82
Tax	0.30	0.07	0.11	0.02	0.09	-0.04	0.19	0.12
Net Profit	1.67	3.69	0.52	3.17	4.36	5.05	3.69	4.70
Eps in Rs	0.83	1.84	0.26	1.58	2.16	2.52	1.86	2.35